Heart Sense is a team led by dr Grzegorz Suwalski, which has set itself the goal of increasing the effectiveness and safety of coronary artery bypass surgery - this is the most commonly performed cardiac surgery in the world - in 2016, a total of 833,000. The team is developing an innovative device recording electrocardiographic (ECG) signal directly from the surface of the beating heart. Scientific data and clinical practice indicate that the introduction of such a device will bring benefits to patients (reduction in the number of complications), doctors (facilitation of surgery) and will be more economical (less invasive and cheaper operations). The electrode, which is a key element of the device, will have the form of a "petal" having the ability to connect to the surface of the heart. It will be produced in technology enabling the production of cheap, single-use items.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Ul. Krzemowa, 1,poland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- heartsense.pl
- HQ
- Suchy Las, Wielkopolskie
Heart Sense Questions
Heart Sense's website is heartsense.pl
Heart Sense's LinkedIn profile is https://pl.linkedin.com/company/heart-sense
Heart Sense has
2 employees.
View email and phone details for 2
employees at Heart Sense.
Heart Sense's industry is
Biotechnology Research
Heart Sense's top competitors are
Vastmed, Llc,
Heart Guard,
Quantum Innovations,
Corflow,
Fibiomed,
Heart Senses,
Naukowe Koło Chemii Medycznej I Środowiskowej,
Innovations For Heart And Vessels Sp. Z O.o.,
Temed Ltd,
Quantum Innovations.
Heart Sense's categories are Biotechnology Research
Heart Sense's founding year is 2019
